Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VWF Antikörper (AA 1304-1452)

VWF Reaktivität: Ratte, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN3042349
  • Target Alle VWF Antikörper anzeigen
    VWF (Von Willebrand Factor (VWF))
    Bindungsspezifität
    • 33
    • 16
    • 11
    • 10
    • 7
    • 5
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1304-1452
    Reaktivität
    • 150
    • 36
    • 25
    • 5
    • 4
    • 3
    Ratte, Maus
    Wirt
    • 85
    • 81
    • 12
    • 5
    Kaninchen
    Klonalität
    • 95
    • 85
    • 1
    Polyklonal
    Konjugat
    • 93
    • 20
    • 15
    • 6
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser VWF Antikörper ist unkonjugiert
    Applikation
    • 103
    • 101
    • 70
    • 57
    • 49
    • 43
    • 27
    • 18
    • 16
    • 15
    • 14
    • 9
    • 9
    • 8
    • 8
    • 5
    • 5
    • 5
    • 4
    • 3
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Verwendungszweck
    Rabbit IgG polyclonal antibody for von Willebrand factor(VWF) detection. Tested with WB, IHC-P in Mouse,Rat.
    Kreuzreaktivität (Details)
    No cross reactivity with other proteins.
    Produktmerkmale
    Rabbit IgG polyclonal antibody for von Willebrand factor(VWF) detection. Tested with WB, IHC-P in Mouse,Rat.
    Gene Name: von Willebrand factor
    Protein Name: von Willebrand factor
    Aufreinigung
    Immunogen affinity purified.
    Immunogen
    E.coli-derived mouse VWF recombinant protein (Position: M1304-E1452).
    Isotyp
    IgG
    Top Product
    Discover our top product VWF Primärantikörper
  • Applikationshinweise
    WB: Concentration: 0.1-0.5 μg/mL, Tested Species: Mouse, Rat, The detection limit for VWF is approximately 0.25 ng/lane under reducing conditions.
    IHC-P: Concentration: 0.5-1 μg/mL, Tested Species: Mouse, Rat, Epitope Retrieval by Heat: Boiling the paraffin sections in 10 mM citrate buffer, pH 6.0, for 20 mins is required for the staining of formalin/paraffin sections.
    Notes: Tested Species: Species with positive results. Other applications have not been tested. Optimal dilutions should be determined by end users.
    Kommentare

    Antibody can be supported by chemiluminescence kit ABIN921124 in WB, supported by ABIN921231 in IHC(P).

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
    Konzentration
    500 μg/mL
    Buffer
    Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    At -20°C for one year. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20 °C for a longer time. Avoid repeated freezing and thawing.
  • Zhang, Zhou, Zhou, Zhao, Chai, Liu, Zheng, Wang, Wang, Zhao: "Preparation of a nano- and micro-fibrous decellularized scaffold seeded with autologous mesenchymal stem cells for inguinal hernia repair." in: International journal of nanomedicine, Vol. 12, pp. 1441-1452, (2017) (PubMed).

    Zhang, Zhao, Zhao, Gu, Peng, Pu, Wu: "Expression and correlation analysis of RegIV and vascular endothelial growth factors (VEGF-A and VEGF-C) in metastatic spinal tumors." in: Oncology letters, Vol. 13, Issue 5, pp. 3517-3521, (2017) (PubMed).

    Zhang, Li, Zheng, Lin, Zhang, Zhang: "Inhibition of angiogenesis by arsenic trioxide via TSP-1-TGF-β1-CTGF-VEGF functional module in rheumatoid arthritis." in: Oncotarget, Vol. 8, Issue 43, pp. 73529-73546, (2017) (PubMed).

    Mu, Song, Zhang, Lin, Dong: "Calcium signaling is implicated in the diffuse axonal injury of brain stem." in: International journal of clinical and experimental pathology, Vol. 8, Issue 5, pp. 4388-97, (2016) (PubMed).

    Ding, Chen, Xu, Qin: "Effect of Hyperbaric Oxygen on the Growth of Intracranial Glioma in Rats." in: Chinese medical journal, Vol. 128, Issue 23, pp. 3197-203, (2016) (PubMed).

    Pan, Yu, Huang, Zhu: "Resveratrol Protects against TNF-α-Induced Injury in Human Umbilical Endothelial Cells through Promoting Sirtuin-1-Induced Repression of NF-KB and p38 MAPK." in: PLoS ONE, Vol. 11, Issue 1, pp. e0147034, (2016) (PubMed).

    Yang, Yang, Cao, Man, Li, Xing: "Paxillin regulates vascular endothelial growth factor A-induced in vitro angiogenesis of human umbilical vein endothelial cells." in: Molecular medicine reports, Vol. 11, Issue 3, pp. 1784-92, (2015) (PubMed).

    Qi, Li, Zhang, Zhang, Wang, Zhang, Gui, Huang: "Correction: IFI6 Inhibits Apoptosis via Mitochondrial-Dependent Pathway in Dengue Virus 2 Infected Vascular Endothelial Cells." in: PLoS ONE, Vol. 10, Issue 9, pp. e0138896, (2015) (PubMed).

    Wang, Jiang, Wang, Li, Zhang, Zhao, Peng, Cao, Sun: "Construction of tissue-engineered bone using a bioreactor and platelet-rich plasma." in: Experimental and therapeutic medicine, Vol. 8, Issue 2, pp. 413-418, (2014) (PubMed).

    Zhu, Tuerxun, Hui, Abliz: "Effects of propranolol and isoproterenol on infantile hemangioma endothelial cells in vitro." in: Experimental and therapeutic medicine, Vol. 8, Issue 2, pp. 647-651, (2014) (PubMed).

    Wu, Chen, Guo, He, Hu: "Effects of transforming growth factor-?2 on myocilin expression and secretion in human primary cultured trabecular meshwork cells." in: International journal of clinical and experimental pathology, Vol. 7, Issue 8, pp. 4827-36, (2014) (PubMed).

    Han, Jia, Dai, Yang, Zhao, Zhao, Fan, Yuan: "Performance of a multilayered small-diameter vascular scaffold dual-loaded with VEGF and PDGF." in: Biomaterials, Vol. 34, Issue 30, pp. 7302-13, (2013) (PubMed).

    Yang, Qin, Wang, Chen, Yuan, Fang, Yao, Jiao, Yu, Zhang, Wang: "Pinocembrin, a major flavonoid in propolis, improves the biological functions of EPCs derived from rat bone marrow through the PI3K-eNOS-NO signaling pathway." in: Cytotechnology, Vol. 65, Issue 4, pp. 541-51, (2013) (PubMed).

    Liu, Zhang, Hou, Wang, Yang, Guan, Dong, Gao, Feng: "Vascularized bone tissue formation induced by fiber-reinforced scaffolds cultured with osteoblasts and endothelial cells." in: BioMed research international, Vol. 2013, pp. 854917, (2013) (PubMed).

    Xu, Fu, Chen, Xiao, Lan, Le, Cheng, He, Shen, Huang, Liu: "Development of an optimized protocol for primary culture of smooth muscle cells from rat thoracic aortas." in: Cytotechnology, Vol. 61, Issue 1-2, pp. 65-72, (2010) (PubMed).

    Zhao, Chen, Li, Xu: "PlexinA1 expression in gastric carcinoma and its relationship with tumor angiogenesis and proliferation." in: World journal of gastroenterology, Vol. 13, Issue 48, pp. 6558-61, (2007) (PubMed).

    Jiang, Xu, Zhu, Chen, Qian, Qiao, Yang, Wang, Chen: "Histological type of oncogenity and expression of cell cycle genes in tumor cells from human mesenchymal stem cells." in: Oncology reports, Vol. 16, Issue 5, pp. 1021-8, (2006) (PubMed).

  • Target
    VWF (Von Willebrand Factor (VWF))
    Andere Bezeichnung
    VWF (VWF Produkte)
    Synonyme
    VWF antikoerper, si:ch1073-474e24.1 antikoerper, F8VWF antikoerper, VWD antikoerper, 6820430P06Rik antikoerper, AI551257 antikoerper, B130011O06Rik antikoerper, C630030D09 antikoerper, von Willebrand factor antikoerper, Von Willebrand factor antikoerper, VWF antikoerper, vwf antikoerper, Vwf antikoerper
    Hintergrund
    Von Willebrand factor (VWF) is a blood glycoprotein involved in hemostasis. It is mapped to 12p13.31. The VWF gene encodes von Willebrand factor (VWF), a large multimeric glycoprotein that plays a central role in the blood coagulation system, serving both as a major mediator of platelet-vessel wall interaction and platelet adhesion, and as a carrier for coagulation factor VIII. VWF released from endothelial cell Weibel-Palade bodies bound particularly avidly to the extracellular matrix. VWF deficiency or dysfunction (von Willebrand disease) leads to a bleeding tendency, which is most apparent in tissues having high blood flow shear in narrow vessels.

    Synonyms: Coagulation factor VIII antibody|Coagulation factor VIII VWF antibody|F8VWF antibody|Factor VIII related antigen antibody|von Willebrand antigen 2 antibody|Von Willebrand antigen II antibody|Von Willebrand disease antibody|VWD antibody|VWF antibody|VWF_HUMAN antibody
    Gen-ID
    22371
Sie sind hier:
Kundenservice